Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial
Agnetha D. Fruijtier(Amsterdam UMC Location University of Amsterdam), Leonie N.C. Visser(Utrecht University), Wiesje M. van der Flier(Amsterdam Neuroscience), Ingrid S. van Maurik(Amsterdam Neuroscience), Femke H. Bouwman(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jarith L. Ebenau(MACOM (United States)), Bart N.M. van Berckel(Amsterdam Neuroscience), Jetske van der Schaar(Amsterdam Neuroscience), Marissa D. Zwan(Amsterdam UMC Location VUmc), Ellen M.A. Smets(Amsterdam University Medical Centers), Yolande A.L. Pijnenburg(Amsterdam Neuroscience), Philip Scheltens(Amsterdam University Medical Centers)
Cited by 29
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k